Previous research examining vitamin D status and VDR expression in relation to other gynecologic diseases has found that high systemic 25(OH)D levels and strong tissue VDR expression are associated with a reduced risk of gynecologic malignancies, including ovarian and endometrial cancer [42,43,44]. Here, VDR is linked to female reproductive system disorder.